<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Intramyocellular <z:chebi fb="23" ids="18059">lipids</z:chebi>, including <z:chebi fb="7" ids="17761">ceramide</z:chebi>, a second messenger in the <z:chebi fb="0" ids="17636">sphingomyelin</z:chebi> signalling pathway, might contribute to the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of our study was to assess parameters of the skeletal muscle <z:chebi fb="0" ids="17636">sphingomyelin</z:chebi> signalling pathway in men at risk of developing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We studied 12 lean (BMI &lt; 25 kg/m(2)) men without a family history of <z:mp ids='MP_0002055'>diabetes</z:mp> (control group), 12 lean male offspring of type 2 diabetic patients, and 21 men with overweight or <z:hpo ids='HP_0001513'>obesity</z:hpo> comprising 12 with NGT (<z:mp ids='MP_0001261'>obese</z:mp>-NGT) and nine with IGT (<z:mp ids='MP_0001261'>obese</z:mp>-IGT) </plain></SENT>
<SENT sid="3" pm="."><plain>A euglycaemic-hyperinsulinaemic clamp and a biopsy of vastus lateralis muscle were performed </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="7" ids="17761">Ceramide</z:chebi>, <z:chebi fb="0" ids="17636">sphingomyelin</z:chebi>, <z:chebi fb="0" ids="16566">sphinganine</z:chebi> and <z:chebi fb="0" ids="16393">sphingosine</z:chebi> levels and sphingomyelinase and ceramidase activities were measured in muscle </plain></SENT>
<SENT sid="5" pm="."><plain>Muscle diacylglycerol and triacylglycerol levels were estimated in a subgroup of 27 men (comprising men from <z:hpo ids='HP_0000001'>all</z:hpo> the above groups) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Compared with the control group, the lean offspring of diabetic patients and the men with overweight or <z:hpo ids='HP_0001513'>obesity</z:hpo> showed lower insulin sensitivity (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.005) and a greater muscle <z:chebi fb="7" ids="17761">ceramide</z:chebi> level (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:mp ids='MP_0001261'>obese</z:mp>-IGT group had lower insulin sensitivity (p = 0.0018) and higher muscle <z:chebi fb="7" ids="17761">ceramide</z:chebi> (p = 0.0022) than the <z:mp ids='MP_0001261'>obese</z:mp>-NGT group </plain></SENT>
<SENT sid="8" pm="."><plain>There was lower muscle <z:chebi fb="0" ids="16393">sphingosine</z:chebi> level and alkaline ceramidase activity in offspring of diabetic patients (p = 0.038 and p = 0.031, respectively) and higher <z:chebi fb="0" ids="16566">sphinganine</z:chebi> level in the <z:mp ids='MP_0001261'>obese</z:mp>-NGT (p = 0.049) and <z:mp ids='MP_0001261'>obese</z:mp>-IGT (p = 0.002) groups than in the control group </plain></SENT>
<SENT sid="9" pm="."><plain>Muscle <z:chebi fb="0" ids="17636">sphingomyelin</z:chebi> was lower (p = 0.0028) and neutral sphingomyelinase activity was higher (p = 0.00079) in the <z:mp ids='MP_0001261'>obese</z:mp>-IGT than in the <z:mp ids='MP_0001261'>obese</z:mp>-NGT group </plain></SENT>
<SENT sid="10" pm="."><plain>Muscle <z:chebi fb="7" ids="17761">ceramide</z:chebi> was related to insulin sensitivity independently of other muscle <z:chebi fb="23" ids="18059">lipid</z:chebi> fractions </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATIONS: <z:chebi fb="7" ids="17761">Ceramide</z:chebi> accumulates in muscle of men at risk of developing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>